We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Algorithm Detects 30% Of Breast Cancers Missed on MRI Scans

By MedImaging International staff writers
Posted on 07 Nov 2024

In the United States, more than 500,000 women participate in supplemental breast magnetic resonance imaging (MRI) screenings each year. These women are considered to be at an elevated risk for breast cancer. Following a negative screening mammogram, supplemental MRI can uncover an additional 15 to 18 cancers per 1,000 high-risk women. Thanks to the higher sensitivity of MRI compared to mammography, it may be feasible to estimate an individual's risk of developing cancer within the upcoming year based on their most recent negative screening MRI. Researchers have proposed that current MRI examinations contain valuable information regarding the outcome of the next annual screening. Based on this hypothesis, they have developed and assessed an artificial intelligence (AI) algorithm to identify breast cancer in MRI scans up to one year earlier than when radiologists typically detect it, potentially improving early detection among high-risk women.

A research team from The City College of New York (New York, NY, USA) fine-tuned a convolutional neural network (CNN) AI model, which was pre-trained on breast MRI data, utilizing a retrospective dataset that included 3,029 MRI scans from 910 patients. This dataset contained 115 cancers diagnosed within a year of a negative MRI result. The model aimed to identify these cancers to predict the development of cancer as much as one year in advance. The network was fine-tuned and validated using a 10-fold cross-validation method. The mean age of the patients involved was 52 years, ranging from 18 to 88 years, with an average follow-up duration of 4.3 years, spanning from 1 to 12 years.

The AI was able to detect cancers a year earlier, achieving an area under the ROC curve of 0.72. A retrospective review by a radiologist of the top 10% highest risk MRIs, as ranked by the AI, could have boosted early detection by up to 30%. The radiologist identified a visual marker for biopsy-proven cancers in 83 MRI scans from the previous year. The AI algorithm pinpointed the anatomical regions where cancer would be detected in 66 cases, with agreement between the two methods in 54 instances. Based on the findings published in Academic Radiology, the researchers concluded that their innovative AI-assisted re-evaluation of "benign" breast scans holds promise for enhancing early breast cancer detection through MRI. As datasets expand and image quality continues to improve, they anticipate that this method will become increasingly influential.

New
HF Stationary X-Ray Machine
TR20G
Ultrasound Imaging System
P12 Elite
Digital Radiographic System
OMNERA 300M
X-ray Diagnostic System
FDX Visionary-A
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Ultrasound

view channel
Image: The new type of Sonogenetic EchoBack-CAR T cell (Photo courtesy of Longwei Liu/USC)

Smart Ultrasound-Activated Immune Cells Destroy Cancer Cells for Extended Periods

Chimeric antigen receptor (CAR) T-cell therapy has emerged as a highly promising cancer treatment, especially for bloodborne cancers like leukemia. This highly personalized therapy involves extracting... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.